IBDEI125 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17966,1,3,0)
 ;;=3^Osteopenia
 ;;^UTILITY(U,$J,358.3,17966,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,17966,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,17967,0)
 ;;=M81.0^^76^859^75
 ;;^UTILITY(U,$J,358.3,17967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17967,1,3,0)
 ;;=3^Osteoporosis,Age-Related w/o Fx
 ;;^UTILITY(U,$J,358.3,17967,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,17967,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,17968,0)
 ;;=G62.9^^76^859^76
 ;;^UTILITY(U,$J,358.3,17968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17968,1,3,0)
 ;;=3^Peripheral Neuropathy
 ;;^UTILITY(U,$J,358.3,17968,1,4,0)
 ;;=4^G62.9
 ;;^UTILITY(U,$J,358.3,17968,2)
 ;;=^5004079
 ;;^UTILITY(U,$J,358.3,17969,0)
 ;;=B59.^^76^859^77
 ;;^UTILITY(U,$J,358.3,17969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17969,1,3,0)
 ;;=3^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,17969,1,4,0)
 ;;=4^B59.
 ;;^UTILITY(U,$J,358.3,17969,2)
 ;;=^5000734
 ;;^UTILITY(U,$J,358.3,17970,0)
 ;;=J15.8^^76^859^78
 ;;^UTILITY(U,$J,358.3,17970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17970,1,3,0)
 ;;=3^Pneumonia,Oth Spec Bacteria
 ;;^UTILITY(U,$J,358.3,17970,1,4,0)
 ;;=4^J15.8
 ;;^UTILITY(U,$J,358.3,17970,2)
 ;;=^95571
 ;;^UTILITY(U,$J,358.3,17971,0)
 ;;=J13.^^76^859^79
 ;;^UTILITY(U,$J,358.3,17971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17971,1,3,0)
 ;;=3^Pneumonia,Pneumococcal
 ;;^UTILITY(U,$J,358.3,17971,1,4,0)
 ;;=4^J13.
 ;;^UTILITY(U,$J,358.3,17971,2)
 ;;=^5008170
 ;;^UTILITY(U,$J,358.3,17972,0)
 ;;=J18.9^^76^859^80
 ;;^UTILITY(U,$J,358.3,17972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17972,1,3,0)
 ;;=3^Pneumonia,Unspec
 ;;^UTILITY(U,$J,358.3,17972,1,4,0)
 ;;=4^J18.9
 ;;^UTILITY(U,$J,358.3,17972,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,17973,0)
 ;;=A81.2^^76^859^81
 ;;^UTILITY(U,$J,358.3,17973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17973,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,17973,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,17973,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,17974,0)
 ;;=B86.^^76^859^82
 ;;^UTILITY(U,$J,358.3,17974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17974,1,3,0)
 ;;=3^Scabies
 ;;^UTILITY(U,$J,358.3,17974,1,4,0)
 ;;=4^B86.
 ;;^UTILITY(U,$J,358.3,17974,2)
 ;;=^108096
 ;;^UTILITY(U,$J,358.3,17975,0)
 ;;=T50.905A^^76^859^83
 ;;^UTILITY(U,$J,358.3,17975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17975,1,3,0)
 ;;=3^Side Effect of Medication,Init Encntr
 ;;^UTILITY(U,$J,358.3,17975,1,4,0)
 ;;=4^T50.905A
 ;;^UTILITY(U,$J,358.3,17975,2)
 ;;=^5052160
 ;;^UTILITY(U,$J,358.3,17976,0)
 ;;=J01.90^^76^859^84
 ;;^UTILITY(U,$J,358.3,17976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17976,1,3,0)
 ;;=3^Sinusitis,Acute
 ;;^UTILITY(U,$J,358.3,17976,1,4,0)
 ;;=4^J01.90
 ;;^UTILITY(U,$J,358.3,17976,2)
 ;;=^5008127
 ;;^UTILITY(U,$J,358.3,17977,0)
 ;;=J32.9^^76^859^85
 ;;^UTILITY(U,$J,358.3,17977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17977,1,3,0)
 ;;=3^Sinusitis,Chronic
 ;;^UTILITY(U,$J,358.3,17977,1,4,0)
 ;;=4^J32.9
 ;;^UTILITY(U,$J,358.3,17977,2)
 ;;=^5008207
 ;;^UTILITY(U,$J,358.3,17978,0)
 ;;=R61.^^76^859^86
 ;;^UTILITY(U,$J,358.3,17978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17978,1,3,0)
 ;;=3^Sweats/Night Sweats
 ;;^UTILITY(U,$J,358.3,17978,1,4,0)
 ;;=4^R61.
 ;;^UTILITY(U,$J,358.3,17978,2)
 ;;=^331970
 ;;^UTILITY(U,$J,358.3,17979,0)
 ;;=A51.0^^76^859^88
 ;;^UTILITY(U,$J,358.3,17979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17979,1,3,0)
 ;;=3^Syphilis,Genital,Primary
 ;;^UTILITY(U,$J,358.3,17979,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,17979,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,17980,0)
 ;;=A51.5^^76^859^87
